Skip to content
Sunday, November 22, 2026Independent education · Evidence in contextOur standards
MedicalGenetics.Science for life. Knowledge for care.
HomeGenetics toolsSource watchEveryday geneticsClinical practiceFor researchersArticle libraryTrusted resources
Home2026

Year: 2026

A primary cilium with two protein markers illustrates a cellular context of polycystin biology.
Family & Rare Conditions

PKD1 and PKD2 gene guide: variants, testing limits and ADPKD evidence

November 7, 2026 Medical Genetics editorial team Comments Off on PKD1 and PKD2 gene guide: variants, testing limits and ADPKD evidence
Interpret PKD1 and PKD2 results with attention to exact variants, pseudogenes, assay coverage, family findings and the limits of individual prognosis.

[…]

A kidney with schematic cyst spaces represents cystic disease; it does not distinguish all causes.
Family & Rare Conditions

ADPKD: polycystic kidney disease, diagnosis and family next steps

November 7, 2026 Medical Genetics editorial team Comments Off on ADPKD: polycystic kidney disease, diagnosis and family next steps
Understand autosomal dominant polycystic kidney disease: kidney cysts, imaging and genetic tests, blood pressure, family assessment and research outcomes.

[…]

A signalling switch with a braking element represents neurofibromin regulation of RAS activity.
Cancer Genetics

NF1 gene guide: neurofibromin, variant interpretation and mosaicism

November 7, 2026 Medical Genetics editorial team Comments Off on NF1 gene guide: neurofibromin, variant interpretation and mosaicism
Understand an NF1 genetic finding: neurofibromin biology, inherited versus tumor context, mosaicism, testing limits and a practical evidence worksheet.

[…]

A stylized patch of skin with pigment marks represents one possible NF1 feature, not a diagnostic photograph.
Cancer Genetics

Neurofibromatosis type 1: signs, diagnosis, monitoring and family questions

November 7, 2026 Medical Genetics editorial team Comments Off on Neurofibromatosis type 1: signs, diagnosis, monitoring and family questions
A clear NF1 guide explaining skin findings, diagnostic assessment, age-related features, monitoring, family implications and questions for specialist care.

[…]

A lysosomal compartment with accumulated lipid-like material represents Gaucher disease conceptually.
Family & Rare Conditions

Gaucher disease: symptoms, enzyme testing, genetics and ongoing care

November 7, 2026 Medical Genetics editorial team Comments Off on Gaucher disease: symptoms, enzyme testing, genetics and ongoing care
Understand Gaucher disease, enzyme and GBA1 testing, major clinical forms, treatment goals and a practical plan for specialist follow-up.

[…]

A cell-surface receptor with an activation marker illustrates receptor signalling; variant effects differ.
Children & Development

FGFR3 gene guide: achondroplasia variants, signaling and clinical context

November 7, 2026 Medical Genetics editorial team Comments Off on FGFR3 gene guide: achondroplasia variants, signaling and clinical context
Understand FGFR3 gain-of-function, common achondroplasia variants, other gene-associated conditions and the difference between constitutional and tumor findings.

[…]

A long-bone schematic highlights the growth plate as one relevant site in achondroplasia.
Children & Development

Achondroplasia: diagnosis, lifelong care and practical family questions

November 7, 2026 Medical Genetics editorial team Comments Off on Achondroplasia: diagnosis, lifelong care and practical family questions
A respectful guide to achondroplasia: FGFR3, diagnosis, early health assessment, lifelong support and questions for skeletal dysplasia specialists.

[…]

Blood and tumour sample contexts illustrate why the origin of a TP53 finding requires assessment.
Cancer Genetics

TP53 gene guide: inherited findings, tumor variants and blood-cell clones

November 7, 2026 Medical Genetics editorial team Comments Off on TP53 gene guide: inherited findings, tumor variants and blood-cell clones
Interpret TP53 results with the specimen, classification and clinical context: constitutional variants, tumor findings, mosaicism and clonal hematopoiesis.

[…]

A shield and a DNA marker represent genome-protection biology and predisposition, not protection from all cancer.
Cancer Genetics

Li–Fraumeni syndrome: TP53, cancer surveillance and family next steps

November 7, 2026 Medical Genetics editorial team Comments Off on Li–Fraumeni syndrome: TP53, cancer surveillance and family next steps
Understand Li–Fraumeni syndrome, confirmed TP53 findings, specialist surveillance, family testing and questions to ask before interpreting cancer risk.

[…]

A regulatory gate represents APC-associated control of WNT/beta-catenin signalling.
Cancer Genetics

APC gene guide: polyposis variants, tumor findings and family interpretation

November 7, 2026 Medical Genetics editorial team Comments Off on APC gene guide: polyposis variants, tumor findings and family interpretation
Read an APC result carefully: tumor-suppressor biology, constitutional versus tumor findings, testing scope, uncertainty and family assessment.

[…]

Posts pagination

« 1 … 6 7 8 … 13 »

Recent Posts

  • Personalised base editing: what an individual-patient result can show
  • Newborn genome screening: benefits, limits and follow-up
  • 22q11.2 deletion syndrome: one genetic diagnosis, different health needs
  • X-linked hypophosphatemia: connect phosphate loss with PHEX testing
  • TTR T60A (Thr80Ala): what the variant name means

Recent Comments

No comments to show.
Medical Genetics

Clear explanations. Traceable evidence. A thoughtful view of genetics across everyday life, clinical care and research.

Publisher & medical editor: Saeed Reza Ghaffari, MD, MSc, PhD
Medical Genetics Specialist · About the publisher

Learning resourcesTrusted resourcesSource watchAboutEditorial policyPrivacyContact
© 2026 Medical Genetics. Educational information, not individual medical advice. Article review status and sources are shown separately. No affiliation with similarly named journals or professional societies is implied.